New pill combo aims to extend life in tough bile duct cancer
Disease control
Not yet recruiting
This study tests whether adding a new drug (D07001) to standard chemotherapy (capecitabine) helps people with advanced bile duct cancer live longer. It is for patients whose cancer has stopped responding to earlier treatments. About 195 adults will receive either D07001 or a plac…
Phase: PHASE3 • Sponsor: InnoPharmax Inc. • Aim: Disease control
Last updated May 05, 2026 11:56 UTC